Talk to Patients About: Measles

Texas Medicine
|February 5, 2019
PubMed

Insights

The measles vaccine, introduced in 1963, dramatically reduced global deaths from the disease. Vaccination programs have saved millions of lives, transforming measles from a deadly threat to a largely preventable illness.

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • Measles was a significant global cause of mortality before widespread vaccination.
  • In 1963, an estimated 2.6 million deaths occurred annually due to measles.
  • The historical impact of measles underscores the importance of infectious disease control.

Purpose of the Study:

  • To highlight the impact of measles vaccination on global mortality.
  • To demonstrate the effectiveness of public health interventions in disease prevention.
  • To contextualize the historical severity of measles for contemporary audiences.

Main Methods:

  • Analysis of historical mortality data related to measles.
  • Comparison of pre-vaccine era mortality rates with post-vaccine era rates.
  • Evaluation of the impact of vaccination programs on disease-related deaths.

Main Results:

  • The introduction of the measles vaccine in 1963 marked a turning point in disease control.
  • Global measles deaths decreased significantly following the vaccine's implementation.
  • By 2016, measles vaccination programs reduced annual global deaths to approximately 89,000.

Conclusions:

  • Measles vaccination has been a highly successful public health intervention.
  • Vaccination programs have drastically reduced measles-related mortality worldwide.
  • The decline in measles deaths illustrates the power of vaccines in preventing infectious diseases.

Related Concept Videos

Sleepwalking and Sleep Talking01:17

Sleepwalking and Sleep Talking

Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
976
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.0K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
269
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
263
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
234
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259